Penumbra, fresh off its latest entry into the peripheral vascular market, last week registered for an initial public offering worth $115 million. Alameda, Calif.-based Penumbra also makes devices for treating neurovascular conditions including hemorrhagic and ischemic stroke. The company reported sales of $125.5 million last year, up 41.3% over 2013. Founded in 2004, Penumbra said it employs […]
A former sales rep for Cardiovascular Systems (NSDQ:CSII) is suing the company, alleging that it ran a kickbacks and off-label marketing scheme to boost sales of its orbital atherectomy devices in violation of the False Claims Act. The lawsuit, filed by ex-rep Travis Thams in July 2013 and unsealed this week, accuses St. Paul, Minn.-based CSI of inducing […]
Medtronic (NYSE:MDT) today touted results from its VeClose clinical trial of its VenaSeal varicose vein treatment, saying the device posted a 96.8% closure rate at 12 months. Results from the study were presented by principal investigator Dr. Nick Morrison of the Morrison Vein Institute in Scottsdale, Ariz., at the the European Venous Forum 2015 in St. Petersburg, Russia. VenaSeal […]
Terumo (TYO:4543) said today that it launched the Misago RX self-expanding peripheral stent in the U.S. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago. The stent is designed to treat patients with peripheral artery disease in the superficial femoral artery or proximal popliteal artery, the Tokyo-based company said. “The Misago stent […]
Shockwave Medical announced $40 million in funding for its novel balloon catheter designed to treat calcified lesions in the peripheral vasculature.
Intact Vascular said it brought in a $38.9 million Series B round it plans to use to get its Tack endovascular device through the FDA approval process.
Intact Vascular said a 1st-in-human study of a device designed to repair arterial dissections after angioplasty has produced encouraging results.